Apellis Pharmaceuticals buy Sievi
Start price
08.08.23
/
50%
€22.40
Target price
08.09.23
-
Performance (%)
29.46%
End price
21.08.23
€29.00
Summary
This prediction ended on 21.08.23 with a price of €29.00. The prediction had a final performance of 29.46%. Sievi has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Apellis Pharmaceuticals | - | - |
| iShares Core DAX® | -0.268% | 5.471% |
| iShares Nasdaq 100 | 1.854% | 7.851% |
| iShares Nikkei 225® | 0.284% | 1.729% |
| iShares S&P 500 | 1.178% | 5.269% |
According to Sievi what are the pros and cons of Apellis Pharmaceuticals for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year